186 related articles for article (PubMed ID: 18510642)
1. Pharmacogenetics of immunosuppressants: progress, pitfalls and promises.
Cattaneo D; Baldelli S; Perico N
Am J Transplant; 2008 Jul; 8(7):1374-83. PubMed ID: 18510642
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation.
Ng FL; Holt DW; MacPhee IA
Expert Opin Pharmacother; 2007 Sep; 8(13):2045-58. PubMed ID: 17714059
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics?
Burckart GJ; Liu XI
Ther Drug Monit; 2006 Feb; 28(1):23-30. PubMed ID: 16418689
[TBL] [Abstract][Full Text] [Related]
4. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.
Hesselink DA; Bouamar R; Elens L; van Schaik RH; van Gelder T
Clin Pharmacokinet; 2014 Feb; 53(2):123-39. PubMed ID: 24249597
[TBL] [Abstract][Full Text] [Related]
5. Practicability of pharmacogenetics in transplantation medicine.
van Gelder T; van Schaik RH; Hesselink DA
Clin Pharmacol Ther; 2014 Mar; 95(3):262-4. PubMed ID: 23995265
[TBL] [Abstract][Full Text] [Related]
6. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs.
Picard N; Bergan S; Marquet P; van Gelder T; Wallemacq P; Hesselink DA; Haufroid V
Ther Drug Monit; 2016 Apr; 38 Suppl 1():S57-69. PubMed ID: 26469711
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.
Kurzawski M; Droździk M
Pharmacogenomics; 2013 Jul; 14(9):1099-118. PubMed ID: 23837483
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of immunosuppressants: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics (RNPGx).
Woillard JB; Chouchana L; Picard N; Loriot MA;
Therapie; 2017 Apr; 72(2):285-299. PubMed ID: 28318610
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.
Ekbal NJ; Holt DW; Macphee IA
Pharmacogenomics; 2008 May; 9(5):585-96. PubMed ID: 18466104
[TBL] [Abstract][Full Text] [Related]
11. Developmental pharmacogenetics of immunosuppressants in pediatric organ transplantation.
Zhao W; Fakhoury M; Jacqz-Aigrain E
Ther Drug Monit; 2010 Dec; 32(6):688-99. PubMed ID: 21068645
[TBL] [Abstract][Full Text] [Related]
12. Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?
MacPhee IA; Fredericks S; Holt DW
Expert Opin Pharmacother; 2005 Dec; 6(15):2593-605. PubMed ID: 16316299
[TBL] [Abstract][Full Text] [Related]
13. Genetic factors for individual administration of immunosuppressants in organ transplantation.
Yu SF; Wu LH; Zheng SS
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):337-44. PubMed ID: 16911928
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacogenetics of immunosuppressants].
Cojutti PG; Baraldo M
G Ital Nefrol; 2015; 32(2):. PubMed ID: 26005938
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
Mourad M; Wallemacq P; De Meyer M; Malaise J; De Pauw L; Eddour DC; Goffin E; Lerut J; Haufroid V
Transplantation; 2008 Apr; 85(7 Suppl):S19-24. PubMed ID: 18401258
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and immunosuppressive drugs.
Hronová K; Šíma M; Světlík S; Matoušková O; Slanař O
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):821-35. PubMed ID: 25301406
[TBL] [Abstract][Full Text] [Related]
18. The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administration.
Fredericks S; Holt DW; MacPhee IA
Am J Pharmacogenomics; 2003; 3(5):291-301. PubMed ID: 14575518
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update.
Anglicheau D; Legendre C; Beaune P; Thervet E
Pharmacogenomics; 2007 Jul; 8(7):835-49. PubMed ID: 18240909
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients.
Provenzani A; Santeusanio A; Mathis E; Notarbartolo M; Labbozzetta M; Poma P; Provenzani A; Polidori C; Vizzini G; Polidori P; D'Alessandro N
World J Gastroenterol; 2013 Dec; 19(48):9156-73. PubMed ID: 24409044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]